FDA partners with Corning on detector for bogus malaria drugs

04/25/2013 | Reuters · Wall Street Journal, The

Corning will manufacture a handheld, battery-operated device developed by the FDA to detect fake or substandard malaria drugs. The device will be tested first in Ghana, then in other areas where malaria rates are high and counterfeit drugs are common. The FDA plans to distribute the device in coordination with the NIH, CDC, USAID and other organizations.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Director, Payer Marketing
Avalere Health
Washington, DC
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX